450 related articles for article (PubMed ID: 26239609)
1. Congenital generalized lipodystrophies--new insights into metabolic dysfunction.
Patni N; Garg A
Nat Rev Endocrinol; 2015 Sep; 11(9):522-34. PubMed ID: 26239609
[TBL] [Abstract][Full Text] [Related]
2. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.
Shastry S; Delgado MR; Dirik E; Turkmen M; Agarwal AK; Garg A
Am J Med Genet A; 2010 Sep; 152A(9):2245-53. PubMed ID: 20684003
[TBL] [Abstract][Full Text] [Related]
3. Ablation of
Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848133
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophies: disorders of adipose tissue biology.
Garg A; Agarwal AK
Biochim Biophys Acta; 2009 Jun; 1791(6):507-13. PubMed ID: 19162222
[TBL] [Abstract][Full Text] [Related]
5. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.
Akinci B; Onay H; Demir T; Ozen S; Kayserili H; Akinci G; Nur B; Tuysuz B; Nuri Ozbek M; Gungor A; Yildirim Simsir I; Altay C; Demir L; Simsek E; Atmaca M; Topaloglu H; Bilen H; Atmaca H; Atik T; Cavdar U; Altunoglu U; Aslanger A; Mihci E; Secil M; Saygili F; Comlekci A; Garg A
J Clin Endocrinol Metab; 2016 Jul; 101(7):2759-67. PubMed ID: 27144933
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL).
Gomes KB; Pardini VC; Fernandes AP
Clin Chim Acta; 2009 Apr; 402(1-2):1-6. PubMed ID: 19167372
[TBL] [Abstract][Full Text] [Related]
7. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations.
Nishiyama A; Yagi M; Awano H; Okizuka Y; Maeda T; Yoshida S; Takeshima Y; Matsuo M
Pediatr Int; 2009 Dec; 51(6):775-9. PubMed ID: 19438831
[TBL] [Abstract][Full Text] [Related]
8. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders.
Garg A
J Clin Endocrinol Metab; 2011 Nov; 96(11):3313-25. PubMed ID: 21865368
[TBL] [Abstract][Full Text] [Related]
9. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
[TBL] [Abstract][Full Text] [Related]
10. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the
Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786
[TBL] [Abstract][Full Text] [Related]
11. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
[TBL] [Abstract][Full Text] [Related]
12. Metreleptin replacement treatment improves quality of life and psychological well-being in congenital generalized lipodystrophy.
Simsir IY; Yurekli BS; Polat I; Saygili F; Akinci B
Natl Med J India; 2020; 33(5):278-280. PubMed ID: 34213454
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy.
Cortés VA; Curtis DE; Sukumaran S; Shao X; Parameswara V; Rashid S; Smith AR; Ren J; Esser V; Hammer RE; Agarwal AK; Horton JD; Garg A
Cell Metab; 2009 Feb; 9(2):165-76. PubMed ID: 19187773
[TBL] [Abstract][Full Text] [Related]
14. Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family.
Rahman OU; Khawar N; Khan MA; Ahmed J; Khattak K; Al-Aama JY; Naeem M; Jelani M
Diagn Pathol; 2013 May; 8():78. PubMed ID: 23659685
[TBL] [Abstract][Full Text] [Related]
15. Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa.
Al Yaarubi S; Alsagheir A; Al Shidhani A; Alzelaye S; Alghazir N; Brema I; Alsaffar H; Al Dubayee M; Alshahrani A; Abdelmeguid Y; Omar OM; Attia N; Al Amiri E; Al Jubeh J; Algethami A; Alkhayyat H; Haleem A; Al Yahyaei M; Khochtali I; Babli S; Nugud A; Thalange N; Albalushi S; Hergli N; Deeb A; Alfadhel M
Orphanet J Rare Dis; 2024 Mar; 19(1):118. PubMed ID: 38481246
[TBL] [Abstract][Full Text] [Related]
16. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
[TBL] [Abstract][Full Text] [Related]
17. Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants.
Liu Y; Li D; Ding Y; Kang L; Jin Y; Song J; Li H; Yang Y
Eur J Med Genet; 2019 Sep; 62(9):103542. PubMed ID: 30266686
[TBL] [Abstract][Full Text] [Related]
18. [Genetics of congenital lipodystrophies].
Buffet A; Lombes M; Caron P
Ann Endocrinol (Paris); 2015 Oct; 76(6 Suppl 1):S2-9. PubMed ID: 26776286
[TBL] [Abstract][Full Text] [Related]
19. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.
Agarwal AK; Garg A
Trends Endocrinol Metab; 2003 Jul; 14(5):214-21. PubMed ID: 12826327
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
